Abstract
Although metabolic syndrome (MetS) is linked to an elevated risk of cardiovascular disease (CVD), the cardiac-specific risk mechanism is unknown. Obesity, hypertension, and diabetes (all MetS components) are the most common form of CVD and represent risk factors for worse COVID-19 outcomes compared to their non MetS peers. Here, we use obese Yorkshire pigs as a highly relevant animal model of human MetS, where pigs develop the hallmarks of human MetS and reproducibly mimics the myocardial pathophysiology in patients. Myocardium-specific mass spectroscopy-derived metabolomics, proteomics, and transcriptomics enabled the identity and quality of proteins and metabolites to be investigated in the myocardium to greater depth. Myocardium-specific deregulation of pro-inflammatory markers, propensity for arterial thrombosis, and platelet aggregation was revealed by computational analysis of differentially enriched pathways between MetS and control animals. While key components of the complement pathway and the immune response to viruses are under expressed, key N6-methyladenosin RNA methylation enzymes are largely overexpressed in MetS. Blood tests do not capture the entirety of metabolic changes that the myocardium undergoes, making this analysis of greater value than blood component analysis alone. Our findings create data associations to further characterize the MetS myocardium and disease vulnerability, emphasize the need for a multimodal therapeutic approach, and suggests a mechanism for observed worse outcomes in MetS patients with COVID-19 comorbidity.
Introduction
Metabolic Syndrome (MetS)—a cluster of conditions including obesity, hypertension, and hyperglycemia—is a primary driver of cardiovascular disease (CVD). While it is well-established that MetS patients face a significantly higher risk for heart failure and severe COVID-19 outcomes, the specific molecular mechanisms within the heart muscle itself have remained largely uncharacterized. Small animal models often fail to accurately mimic human cardiac anatomy or MetS progression. This study utilizes a high-fidelity large animal model to bridge this gap and map the molecular landscape of the heart under MetS conditions.
Methods
The study utilized Yorkshire pigs, which share similar heart size and coronary anatomy with humans. One group was fed an "obesogenic" high-fat, high-calorie diet for 12 weeks to induce MetS, while the control group received a lean diet (LD). A multi-omic approach was employed, combining transcriptomics (RNA-seq), proteomics (LC-MS/MS), and metabolomics to investigate myocardial tissue. Crucially, findings from the myocardial tissue were compared against systemic blood samples to evaluate the diagnostic accuracy of blood-based biomarkers.
Results
Tissue-Specific Metabolic Dysregulation and Inflammation
A critical finding was the disconnect between blood-based biomarkers and actual tissue-level pathology. For instance, uric acid—a marker of oxidative stress—was significantly elevated in the heart tissue of MetS pigs but appeared normal or even lower in systemic blood. Furthermore, the MetS heart exhibited significant upregulation of pro-inflammatory enzymes such as COX-2 and PTGES2, which are linked to platelet aggregation and arterial thrombosis.
A Pro-thrombotic Cardiac Environment
The MetS myocardium showed a distinct shift toward a hypercoagulable state. Computational analysis revealed an increase in clotting factors (such as Factor VIII and X) alongside a significant decrease in fibrinolytic and anticoagulant proteins, including tPA and Protein C. This "perfect storm" creates a cardiac environment highly susceptible to microvascular thrombosis.
Viral Vulnerability and Immune Evasion
The study identified several mechanisms that may explain worse COVID-19 outcomes in MetS patients. The ratio of ACE (pro-inflammatory) to ACE2 (protective) was significantly higher in MetS pigs. Since ACE2 is the entry point for SARS-CoV-2, its depletion leaves the heart vulnerable to injury. Additionally, there was a significant increase in N6-methyladenosine (m6A) RNA methylation machinery, which viruses can exploit to evade the host's immune system. Conversely, innate antiviral defenses, such as Toll-like receptors (TLRs), were significantly downregulated.
Discussion and Limitations
These findings suggest that MetS creates a molecular setting in the heart characterized by chronic inflammation, hypercoagulability, and impaired innate immunity. This environment likely primes the heart for failure and viral exploitation. However, the study is limited by its 12-week duration, which is short compared to human disease progression, and its focus on young male subjects. Future work should investigate the influence of age and biological sex on these pathways. This research provides a foundational molecular map for developing targeted, multimodal therapies for MetS patients.
Summary updated